Manchester Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-464
| Closed | -$5.37K | – | 1099 |
|
|
2023
Q1 | $5.37K | Sell |
464
-42
| -8% | -$486 | ﹤0.01% | 611 |
|
|
2022
Q4 | $4.14K | Sell |
506
-228
| -31% | -$1.87K | ﹤0.01% | 559 |
|
|
2022
Q3 | $4K | Sell |
734
-5,073
| -87% | -$27.6K | ﹤0.01% | 547 |
|
|
2022
Q2 | $26K | Buy |
5,807
+299
| +5% | +$1.34K | ﹤0.01% | 393 |
|
|
2022
Q1 | $50K | Buy |
5,508
+147
| +3% | +$1.33K | 0.01% | 400 |
|
|
2021
Q4 | $110K | Buy |
5,361
+5,021
| +1,477% | +$103K | 0.01% | 330 |
|
|
2021
Q3 | $9K | Buy |
+340
| New | +$9K | ﹤0.01% | 603 |
|